How quickly does Epclusa clear hepatitis C?
Epclusa (sofosbuvir/velpatasvir) works fast for most patients with chronic hepatitis C virus (HCV) genotypes 1-6. It achieves sustained virologic response (SVR12, meaning undetectable virus 12 weeks post-treatment) in 92-99% of cases, typically after just 12 weeks of once-daily pills—no injections needed.[1][2]
What does 'fast' mean in HCV treatment timelines?
Standard Epclusa regimen is 12 weeks for treatment-naive adults without cirrhosis. With compensated cirrhosis, it's still 12 weeks. Only decompensated cirrhosis or post-transplant cases extend to 24 weeks. Virus levels often drop to undetectable within 4 weeks (end of treatment response rates near 100%), but SVR12 confirms cure.[1][3]
Real patient timelines from clinical trials
- ASTRAL-1 trial (no cirrhosis): 99% SVR12 for genotypes 1-4; rapid viral decline, with >90% undetectable by week 4.[2]
- ASTRAL-2/3 trials (GT2/3): 99% and 95% SVR12; similar quick response.[2]
- ASTRAL-4 (cirrhosis): 94% SVR12 in 12 weeks.[2]
Retreatment cases (with or without cirrhosis) hit 96-100% SVR12 in 12-24 weeks.[1]
Factors affecting how fast it works
Prior treatment failure, cirrhosis stage, or kidney issues (avoid if eGFR <30 mL/min) can influence speed and efficacy. Drug interactions (e.g., with rifampin) reduce effectiveness, potentially prolonging viral clearance. Testing confirms response at weeks 4 and 12.[1][3]
Does it work faster than older HCV drugs?
Yes, compared to interferon-based regimens (24-48 weeks, 50-70% cure rates with harsh side effects), Epclusa cuts treatment to 12 weeks with pan-genotypic coverage and fewer dropouts. Versus Harvoni (genotypes 1/4-6, 8-12 weeks), Epclusa covers all genotypes in similar timeframes.[3]
Common side effects during treatment
Headache, fatigue, nausea hit 10-20% of patients early on but rarely stop therapy. No major delays from side effects in trials.[1]
[1]: Epclusa Prescribing Information (Gilead)
[2]: NEJM: Sofosbuvir and Velpatasvir for HCV (ASTRAL Trials)
[3]: FDA Label for Epclusa